Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part II
Ophthalmology in Russia , Volume 17; doi:10.18008/1816-5095-2020-4-676-682
Abstract: Topical and systemic carbonic anhydrase inhibitors (CAIs) are widely used in the treatment of glaucoma for reducing intraocular pressure. This part of the review describes the characteristics of systemic CAIs, their side effects and the ways to overcome them, as well as contraindications. The use of CAIs during pregnancy is considered. Particular attention is paid to the antioxidant activity of CAIs and the promising development of hybrid forms based on the existing CAIs as a part of a multipurpose glaucoma treatment strategy.
Keywords: Treatment / antioxidant / glaucoma / systemic / promising / Intraocular / Cais / side / Anhydrase Inhibitors
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Ophthalmology in Russia" .